The global left atrial appendage (LAA) closure devices market is likely to be valued at USD 1,392.44 million by 2027, at a CAGR of 21.5% from 2021–2027. The global market is characterized by a significantly growing geriatric population with a high prevalence of atrial fibrillation. Also, there has been a rising adoption of minimally invasive therapies and various government initiatives to promote LAA closure. Aforementioned factors are likely to drive the market for left atrial appendage (LAA) closure devices over the forecast period.
The left atrial appendage (LAA) is a small, ear-shaped sac in the muscle wall of the left atrium (top left chamber of the heart). If a patient suffers from atrial fibrillation (AF), the electrical impulses controlling the heartbeat do not travel in a regular manner through the heart. Instead, many impulses begin at the same time and spread through the atria. These fast as well as disordered impulses do not give atria the time to contract or effectively squeeze blood into the ventricles. Since LAA is a small pouch, it causes the blood to collect there and may form clots in the LAA and atria. When the blood clots are pumped out of the heart, they can cause a stroke. Patients affected with AF are five times more likely to suffer a stroke than those without the complication.
Segment overview
On the basis of product, the endocardial LAA closure device segment held the largest share of the global market in 2020. Endocardial closure is the most widely used and tested method for the closure of LAAs. The endocardial devices were approved for stand-alone use in the US, as they were in Europe. This was the major factor in expanding the eligible patient pool for LAA closure. Moreover, physicians are familiar with endocardial devices as interventional cardiologists have already been practicing with similar devices for decades
On the basis of end-use, the hospital segment accounted for the largest share of the global market in 2019, and the trend is expected to continue over the coming years. Major factor attributed to the growth of this segment is the presence of more resources in terms of equipment and support departments (MRI suites and ICUs) that can effectively handle major problems during surgical procedures. Additionally, older patients (one of the major demographic for atrial fibrillation) opt for healthcare centres as they might have a strong reaction to anaesthesia, and are more likely to experience surgical complications.
On the basis of region, North America dominated the global market for left atrial appendage (LAA) closure devices in 2020 on account of rising prevalence of cardiovascular disorders, growing awareness among people, and increasing government initiatives. Moreover, presence of various key players such as AtriCure, Inc., Boston Scientific Corporation, and Abbott coupled with better healthcare infrastructure in the region is further propelling the market demand in the region.
The report provides detailed market outlook, and forecast the “Global Left Atrial Appendage (LAA) Closure Devices” market based on product, end-use and region.
| Research Attribute | Coverage |
|---|---|
| Years Considered | 2017-2027 |
| Historical Years | 2017, 2018, 2019 |
| Base Year | 2020 |
| Forecast Period | 2021-2027 |
| Units Considered | USD Million |
| Segmentation By Product |
|
| Segmentation by End-Use |
|
| Regions Covered |
|
| Key Company Profiles | Lifetech Scientific Corporation, AtriCure, Inc., Boston Scientific Corporation, SentreHEART, Inc., Abbott, Cardiac, Inc., Aegis Medical, & Coherex Medical Inc., among others. |
CHAPTER 1. Market Scope and Methodology
1.1. Research methodology
1.2. Objectives of the report
1.3. Research scope & assumptions
1.4. List of data sources
CHAPTER 2. Executive Summary
2.1. Left atrial appendage (LAA) closure devices market – Key industry insights
CHAPTER 3. Market Outlook
3.1. Market definition
3.2. Market segmentation
3.3. Value chain analysis
3.4. Technological overview
3.5. Left atrial appendage (LAA) closure devices market : developed v/s developing countries
3.6. Market opportunities & trends
3.6.1. Growing aging population across the globe
3.6.2. Increasing adoption of minimally invasive therapies
3.6.3. Technological advancements in LAA closure devices
3.7. Market dynamics
3.7.1. Market driver analysis
3.7.1.1. Growing prevalence of atrial fibrillation
3.7.1.2. Favorable government initiatives promoting market growth
3.7.1.3. Impact analysis
3.7.2. Market restraint analysis
3.7.2.1. High cost of LAA closure devices
3.7.2.2. Impact analysis
3.8. Industry analysis – Porter’s
3.8.1. Bargaining power of suppliers
3.8.2. Bargaining power of buyers
3.8.3. Threat of new entrants
3.8.4. Threat of substitutes
3.8.5. Competitive rivalry
3.9. PESTEL analysis
CHAPTER 4. Competitive Outlook
4.1. Competitive framework
4.2. Company market share analysis
4.3. Strategic layout
CHAPTER 5. COVID-19 Implications
5.1. Global industry impact of COVID-19 pandemic
5.1.1. Impact analysis by end-use
5.1.2. Analyst recommendations
CHAPTER 6. Global Left Atrial Appendage (LAA) Closure Devices Market Size and Forecast (2017 - 2027)
6.1. Global Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
6.1.1. Endocardial LAA Closure Devices
6.1.2. Epicardial LAA Closure Devices
6.2. Global Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
6.2.1. Hospitals
6.2.2. Ambulatory Surgical Centers
6.2.3. Others
6.3. Global Left Atrial Appendage (LAA) Closure Devices Market, By Region (USD Million)
6.3.1. North America
6.3.2. Europe
6.3.3. Asia-Pacific
6.3.4. Central & South America (CSA)
6.3.5. Middle East & Africa (MEA)
CHAPTER 7. Global Left Atrial Appendage (LAA) Closure Devices Market Size and Forecast, By Region (2017 - 2027)
7.1. North America Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.1.1. North America Left Atrial Appendage (LAA) Closure Devices Market, By Country (USD Million)
7.1.2. North America Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.1.3. North America Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.1.4. The U.S. Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.1.4.1. The U.S. Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.1.4.2. The U.S. Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.1.5. Canada Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.1.5.1. Canada Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.1.5.2. Canada Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.1.6. Mexico Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.1.6.1. Mexico Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.1.6.2. Mexico Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.2. Europe Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.2.1. Europe Left Atrial Appendage (LAA) Closure Devices Market, By Country (USD Million)
7.2.2. Europe Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.2.3. Europe Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.2.4. Germany Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.2.4.1. Germany Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.2.4.2. Germany Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.2.5. The U.K Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.2.5.1. The U.K Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.2.5.2. The U.K Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.2.6. France Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.2.6.1. France Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.2.6.2. France Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.2.7. Russia Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.2.7.1. Russia Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.2.7.2. Russia Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.2.8. Italy Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.2.8.1. Italy Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.2.8.2. Italy Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.2.9. Spain Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.2.9.1. Spain Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.2.9.2. Spain Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.3. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.3.1. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, By Country (USD Million)
7.3.2. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.3.3. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.3.4. China Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.3.4.1. China Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.3.4.2. China Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.3.5. Japan Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.3.5.1. Japan Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.3.5.2. Japan Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.3.6. India Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.3.6.1. India Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.3.6.2. India Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.4. Central & South America (CSA) Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.4.1. Central & South America (CSA) Left Atrial Appendage (LAA) Closure Devices Market, By Country (USD Million)
7.4.2. Central & South America (CSA) Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.4.3. Central & South America (CSA) Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.4.4. Brazil Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.4.4.1. Brazil Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.4.4.2. Brazil Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.4.5. Argentina Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.4.5.1. Argentina Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.4.5.2. Argentina Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.5. Middle East & Africa (MEA) Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.5.1. Middle East & Africa (MEA) Left Atrial Appendage (LAA) Closure Devices Market, By Country (USD Million)
7.5.2. Middle East & Africa (MEA) Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.5.3. Middle East & Africa (MEA) Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.5.4. Saudi Arabia Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.5.4.1. Saudi Arabia Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.5.4.2. Saudi Arabia Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
7.5.5. South Africa Left Atrial Appendage (LAA) Closure Devices Market (USD Million)
7.5.5.1. South Africa Left Atrial Appendage (LAA) Closure Devices Market, By Product (USD Million)
7.5.5.2. South Africa Left Atrial Appendage (LAA) Closure Devices Market, By End-Use (USD Million)
CHAPTER 8. Key Players and Strategic Developments
8.1. Lifetech Scientific Corporation
8.1.1. Business Overview
8.1.2. Product and Service Offering
8.1.3. Financial Overview
8.1.4. Strategic Developments
8.2. AtriCure, Inc.
8.2.1. Business Overview
8.2.2. Product and Service Offering
8.2.3. Financial Overview
8.2.4. Strategic Developments
8.3. Boston Scientific Corporation
8.3.1. Business Overview
8.3.2. Product and Service Offering
8.3.3. Financial Overview
8.3.4. Strategic Developments
8.4. SentreHEART, Inc.
8.4.1. Business Overview
8.4.2. Product and Service Offering
8.4.3. Financial Overview
8.4.4. Strategic Developments
8.5. Abbott
8.5.1. Business Overview
8.5.2. Product and Service Offering
8.5.3. Financial Overview
8.5.4. Strategic Developments
8.6. Cardiac, Inc.
8.6.1. Business Overview
8.6.2. Product and Service Offering
8.6.3. Financial Overview
8.6.4. Strategic Developments
8.7. Aegis Medical
8.7.1. Business Overview
8.7.2. Product and Service Offering
8.7.3. Financial Overview
8.7.4. Strategic Developments
8.8. Occlutech International AB
8.8.1. Business Overview
8.8.2. Product and Service Offering
8.8.3. Financial Overview
8.8.4. Strategic Developments
8.9. Lepu Medical Technology (Beijing) Co., Ltd.
8.9.1. Business Overview
8.9.2. Product and Service Offering
8.9.3. Financial Overview
8.9.4. Strategic Developments
8.10. Coherex Medical Inc.
8.10.1. Business Overview
8.10.2. Product and Service Offering
8.10.3. Financial Overview
8.10.4. Strategic Developments
